USANA HEALTH SCIENCES INC
For the period ended Mar 29, 2025. Filed May 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 29, 2025 · Filed May 6, 2025
USNA$13.10-5.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Stockholders’ Equity
(in thousands)
For the three months ended March 30, 2024
| Common Stock · AdditionalPaid-inCapital · RetainedEarnings · AccumulatedOtherComprehensiveIncome (Loss) · Total Stockholders' Equity Attributable to USANA | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Shares · Value | |||||||||
| Balance at December 30, 2023 | 19,130 | $19 | $65,661 | $445,217 | $(13,695) | $497,202 | |||
| Net earnings attributable to USANA | 16,537 | 16,537 | |||||||
| Other comprehensive income (loss), net of tax | (4,898) | (4,898) | |||||||
| Equity-based compensation expense | 3,669 | 3,669 | |||||||
| Common stock repurchased and retired | (194) | — | (1,180) | (8,303) | (9,483) | ||||
| Common stock issued under equity award plans | 111 | — | — | ||||||
| Tax withholding for net-share settled equity awards | (3,039) | (3,039) | |||||||
| Balance at March 30, 2024 | 19,047 | $19 | $65,111 | $453,451 | $(18,593) | $499,988 | |||
For the three months ended March 29, 2025
| Common Stock · AdditionalPaid-inCapital · RetainedEarnings · AccumulatedOtherComprehensiveIncome (Loss) · Total Stockholders' Equity Attributable to USANA | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Shares · Value | |||||||||
| Balance at December 28, 2024 | 19,064 | $19 | $75,816 | $478,944 | $(22,670) | $532,109 | |||
| Net earnings attributable to USANA | 9,402 | 9,402 | |||||||
| Other comprehensive income (loss), net of tax | (82) | (82) | |||||||
| Equity-based compensation expense | 2,880 | 2,880 | |||||||
| Common stock repurchased and retired | (399) | — | (1,662) | (10,718) | (12,380) | ||||
| Common stock issued under equity award plans | 121 | — | — | ||||||
| Tax withholding for net-share settled equity awards | (2,167) | (2,167) | |||||||
| Balance at March 29, 2025 | 18,786 | $19 | $74,867 | $477,628 | $(22,752) | $529,762 | |||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.